InTheMoney

The source contains only the title/body phrase "Pain is Coming" with no supporting details, catalysts, assets, sectors, timeframe, or evidence. It is not actionable as-is.

...ying some shares, but if you held if you're a long-term overvalued now but if I buy now over the long term am I going to be like reaping their prospectus, their S1 filing with the SEC? It's beautiful, but it's mostly even mentioned uh about how um XAI That's crazy. And that XAI, what you see gets deducted from the stock price. Um earnings. you don't want it sent out to million but you know EBIDA it's it's all this money into XAI. Capex right now not a lot of cool stuff. I bought like like I d

...t no longer interested. And I already I and [ __ ] off and then the stock getting phone calls all over the all it it segments revenue. Um, as of this calls it a dual monetization. If a revenue. They're getting a ton of revenue from Alphabet and Anthropic, because they're getting all this revenue buying at IPO anyway, it might I don't lining up to buy shares already. It's um $7.7 billion in Q1 of 2026 alone. That's [ __ ] nuts. The total Q1 capex So the AI segment in Q1 is at a minus2.5 millio

The source is a largely incoherent rant centered on a bearish view of SoFi (SOFI), referencing short interest/shorting, and mentions buying puts and briefly buying the Vanguard Growth ETF (VUG). It lacks concrete catalysts, numbers, timing, or a clear repeatable setup beyond a general “short/puts” posture on SOFI.

The source is a largely incoherent rant centered on a bearish view of SoFi (SOFI), referencing short interest/shorting, and mentions buying puts and briefly buying the Vanguard Growth ETF (VUG). It lacks concrete catalysts, numbers, timing, or a clear repeatable setup beyond a general “short/puts” posture on SOFI.

Why SoFi Ain’t It subscriptions revenue top's going up earnings comes around and um we won't shorts and so they're going to you know find companies to short but if you look at the short interest it's like 15% cost you're buying into a stock where we legitimate and then the the stock moons then everyone drops a stock like it's getting [ __ ] like 10 calls in a row than get spam calls from somebody from a bubbles. SL AI on the banking. What who to short, but we don't know whether it's even looked,

Why SoFi Ain’t It subscriptions revenue top's going up earnings comes around and um we won't shorts and so they're going to you know find companies to short but if you look at the short interest it's like 15% cost you're buying into a stock where we legitimate and then the the stock moons then everyone drops a stock like it's getting [ __ ] like 10 calls in a row than get spam calls from somebody from a bubbles. SL AI on the banking. What who to short, but we don't know whether it's even looked,

Post is mostly a personal update and promotion for the author's Discord-based AI chatbot that mimics their personality, answers investing questions, and can critique uploaded portfolio screenshots. It briefly mentions asking the bot why AMD moved, but provides no actual AMD-specific analysis. The health portion says the author had an autoimmune encephalitis flare treated with IVIG, a common therapy, but that it was not effective in their acute phase. Overall, this is very low-value for public-ma

Promotional post for a paid service/video about managing LEAPS (long-dated options), with links to try a product and copy portfolios. No specific market news, catalysts, positions, or tickers disclosed.

Promotional post for a paid service/video about managing LEAPS (long-dated options), with links to try a product and copy portfolios. No specific market news, catalysts, positions, or tickers disclosed.

Promotional/disclaimer post advertising an “Autopilot” copy-trading/portfolio mirroring platform and a paid membership/alerts service. Contains affiliate links and general investing-risk disclaimers, but no company-specific news, financial results, macro data, or actionable trading catalyst tied to any publicly traded ticker.

Personal update from the author about being hospitalized for autoimmune encephalitis flare and receiving IVIG; includes a brief market comment noting a “red morning” but only a “tiny dip” in “CuteDQ” and encourages staying calm (implicit dip-buy / hold Nasdaq exposure).